Since 2009, the most commonly used blood test to evaluate kidney function has used equations that include race as a determining factor. The equations estimate glomerular filtration rate from blood creatinine concentrations. ...
Jun 7, 2022
0
44
For overweight or obese patients with knee osteoarthritis, diet and exercise result in a small but statistically significant difference in knee pain over 18 months compared with an attention control, according to a study ...
Dec 14, 2022
0
3
A new generation of obesity drugs often delivers dramatic weight loss, but many patients wonder what happens when they stop treatment.
Dec 11, 2023
1
27
A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease—the fourth leading cause of death in the United States
May 21, 2023
0
113
Pain in the back or the neck is extremely common and accounts for more health care spending than any other health condition. A study led by investigators from Brigham and Women's Hospital, a founding member of the Mass General ...
Dec 22, 2022
0
3
A novel study that surveyed more than 1,000 author citations in the top three peer-reviewed international medical journals showed a significant disparity regarding women and men faculty and authorship. Led by A. Laurie Shroyer, ...
Apr 21, 2022
0
4
The number of diagnosed cases of attention-deficit/hyperactivity disorder (ADHD) have increased significantly among adults in the United States within the past decade, which could be due to many factors, including overdiagnosis. ...
Apr 17, 2023
0
3
About 13,200 men and another 2,300 women in the United States over age 50 are estimated to have VEXAS syndrome, according to a new study. Long considered a mystery illness until its genetic basis was identified in 2020, the ...
Jan 24, 2023
0
41
CT scans are better at predicting a middle-aged person's risk for a heart disease, such as a heart attack, than genetics, reports a new Northwestern Medicine study published May 23 in JAMA.
May 23, 2023
0
265
A second Alzheimer's drug proven to slow cognitive decline was a step closer to US approval on Monday after clinical trial results published in a top journal confirmed its efficacy.
Jul 22, 2023
0
9
